Our Transactions
Leadership across the largest and most complex situations
Lead Financial Advisor
on its pending €8.0 billion
acquisition of
from Vodafone Group
2024
Exclusive Financial Advisor
on its pending ~$2.3 billion
acquisition of
2024
Independent Financial Advisor
on its pending acquisition of three fill-finish sites for an upfront payment of $11 billion from Novo Holdings following its $16.5 billion acquisition of Catalent
2024
Exclusive Financial Advisor
on its pending ~$35 billion
acquisition of
2024
Exclusive Financial Advisor
on its pending ~$12.6 billion
sale to
2024
Lead Financial Advisor
on its pending $11.5 billion
all-stock merger with
2024
Lead Financial Advisor
on its pending ~$13.4 billion
sale to
2023
Financial Advisor
on its pending ~$14.9 billion
sale to
2023
Financial Advisor
on its pending $60 billion
all-stock acquisition of
2023
Financial Advisor
on its up to $5.8 billion
acquisition of
2023
Financial Advisor
on its pending ~$20 billion
merger with
2023
Lead Left Bookrunner
$300 million
Follow-on Offering
2023
Exclusive Financial Advisor
on its chapter 11 restructuring of ~$1.9 billion of debt and $125 million DIP ABL financing
2023
Active Bookrunner
$1.1 billion IPO & $1.6 billion
Follow-on Offering
2023
Exclusive Financial Advisor
on its pre-packaged chapter 11 restructuring of ~$3.6 billion of debt and preferred equity
2023
Lead Financial Advisor
on its ~$36 billion
spin-off of
2021
Anouncement Date1
Status
Transaction
Value (M)
March 28, 2024
Pending
Advising an Ad Hoc Group on Aventiv’s Comprehensive Out-of-Court Restructuring
~$1,600
March 28, 2024
Pending
Advising Keysight Technologies on its recommended competing cash offer for Spirent Communications
~£1,200
March 25, 2024
Pending
Advising Nuvation Bio on its acquisition of AnHeart Therapeutics
~$300
March 25, 2024
Pending
Advising n2y on its merger with Texthelp
N/A
March 22, 2024
Pending
Advising HBX Group on the Refinancing & Repricing of its secured term loans
~€1,600
March 22, 2024
Pending
Advising Triple Private Equity on its acquisition of a majority stake in SmartSearch
N/A
March 20, 2024
Closed
Advised the Coordinating Committee of the Lender Syndicate on EnerMech’s Comprehensive Restructuring Transaction
N/A
March 19, 2024
Closed
Acted as a Joint Bookrunner on Astera Labs' initial public offering
$820
March 19, 2024
Pending
Advising the Board of IFF in the context of the sale of its Pharma Solutions business to Roquette
$2,850
March 18, 2024
Closed
Acted as a Placement Agent for Spyre Therapeutics' PIPE financing
$180
1Announcement date for M&A transactions represents the date publicly announced; announcement date for restructurings represents the date publicly announced or filed; announcement date for capital markets transactions represents the pricing date.